NSE - Delayed Quote INR
Neuland Laboratories Limited (NEULANDLAB.NS)
At close: 3:29 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
3/31/2020
Operating Cash Flow
--
2,611,767.00
2,372,119.00
603,888.00
1,893,617.00
--
Investing Cash Flow
--
-1,496,868.00
-614,985.00
-955,163.00
-844,237.00
--
Financing Cash Flow
--
-692,818.00
-1,357,958.00
377,215.00
-1,136,604.00
--
End Cash Position
--
875,754.00
454,159.00
50,914.00
24,356.00
--
Capital Expenditure
--
-1,436,698.00
-661,285.00
-976,860.00
-1,053,970.00
--
Issuance of Debt
--
88,219.00
30,994.00
451,268.00
363,646.00
--
Repayment of Debt
--
-482,621.00
-1,166,809.00
-222,607.00
-1,260,275.00
--
Free Cash Flow
--
1,175,069.00
1,710,834.00
-372,972.00
839,647.00
--
3/31/2020 - 10/13/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RPGLIFE.NS RPG Life Sciences Limited
2,594.60
-5.65%
LAURUSLABS.NS Laurus Labs Limited
448.50
-3.60%
SOLARA.NS Solara Active Pharma Sciences Limited
781.25
-5.00%
JUBLPHARMA.NS Jubilant Pharmova Limited
1,127.35
-4.74%
STAR.NS Strides Pharma Science Limited
1,553.75
-5.18%
DIVISLAB.NS Divi's Laboratories Limited
5,817.95
-1.81%
FDC.NS FDC Limited
528.55
-1.53%
MANKIND.NS Mankind Pharma Limited
2,565.95
-3.06%
HIKAL.NS Hikal Limited
348.70
-6.06%
PPLPHARMA.NS Piramal Pharma Limited
215.11
-5.69%